Not applicable.
Not applicable.
The present invention relates, generally, to methods and apparatus for analyzing material. Particularly, the invention relates to methods and apparatus for measuring the size distribution of particles in dilate colloids. Most particularly, the invention relates to methods and apparatus for measuring the size distribution of particles within the dilute colloid through variation of the minimum, detected size of aerosolized colloid particles. The technology is useful, for example, for colloid characterization, filter testing, and high purity water system monitoring.
Existing technology in this field is believed to have significant limitations and shortcomings. Specifically, systems used to measure particle size distributions in colloids are limited to particle diameters greater than 25 nm, when such colloids are present at very low concentrations in ultrapure liquids.
Small particles are a major problem for the semiconductor device manufacturing industry. Particles smaller than 50 nm can significantly reduce manufacturing yield of present day semiconductor devices. The ability to measure concentrations, especially low concentrations, of these particles is highly desired. A brief summary of the state of the art is provided in U.S. Pat. Nos. 8,272,253 and 8,573,034.
All US patents and patent applications, and all other published documents mentioned anywhere in this application are incorporated by reference in their entirety.
The present invention provides analysis methods and apparatus which are practical, reliable, accurate and efficient, and which are believed to constitute an improvement over the background technology. In the preferred embodiment, the invention relates to an aerosolization apparatus and method which creates line droplets of the fluid (nebulization) containing particles and dissolved material at concentrations equal to the bulk material Upon evaporation of the liquid, the gas-borne droplet becomes either a particle consisting of non-volatile dissolved material or a particle consisting of a colloid particle and non-volatile dissolved material. At the residue concentrations and particle sizes of interest, these aerosol particles are too small to be detected optically. The particles are then sampled by a condensation particle counter (CPC) with a temporally or spatially varying detection threshold diameter. In the preferred embodiment, the sample introduced to the nebulizer may consist of the unaltered source colloid, a colloid downstream of a sample introduction device, or downstream of a colloid concentrator (employing evaporation and/or cross flow filtration).
The basic method of the invention for determining the size distribution of particles in a fluid, involves forming a stream of aerosol droplets of the fluid, the droplets containing particles and dissolved material, evaporating the droplets to generate particles, and measuring the concentration of particles by varying a detection threshold. The basic system or apparatus for determining the size distribution of particles in a fluid, includes a droplet former for forming a stream of aerosol droplets of the fluid, the droplets containing particles and dissolved material, and a condensation particle detector for evaporating the droplets to generate particles and for measuring the concentration of particles, the condensation particle detector having a variable detection threshold.
In one aspect, the invention relates to a condensation particle counter where the degree of supersaturation is temporally varied by adjusting the temperatures, of the saturated, aerosol stream and/or the walls of the transport cavities on the condensing region. These temperatures may either be adjusted in a stepwise manner or continuously ramped.
In another aspect, the invention relates to a condensation particle counter where the degree of supersaturation is temporally varied by adjusting the ratio of a vapor saturated flow to a dry flow.
In another aspect, the indention relates to a condensation particle counter where the degree of supersaturation is temporally varied by adjusting the vapor content by controlling the mass of vapor delivered to the gas either by adding a controlled amount of liquid to the gas stream or by controlling the exposure of the gas stream to the working fluid surface.
In another aspect, the invention relates to a condensation particle counter where the degree of supersaturation is spatially varied where particles are exposed to an increasing degree of supersaturation. Larger particles (where the onset of condensational growth occurs at a lower supersaturation) have a longer growth period and thus the resulting droplets are larger. By measuring the amount of light scattered by these droplets (larger droplets lead to more scattered light), the size of the original particle can be inferred.
The present invention is believed to involve novel elements, combined in novel ways to yield more than predictable results. The problems solved by the invention were not fully recognized in fee prior art.
The aspects, features, advantages, benefits and objects of the invention will become clear to those skilled in the art by reference to the following description, drawings and claims.
The present invention describes a method for determining the size distribution of particles within a colloid. This is achieved by nebulization of the colloid where upon evaporation of the nebulized droplets, the resulting aerosol consists of particles previously present in the colloid now suspended in a background gas. In the particle sizes of interest, these particles are not detectable by optical means. The concentration of these particles is then measured using a condensation particle counter with a varying minimum detected particle size.
In
Referring to
Referring next to
Referring to
Alternative embodiments of the droplet forming element or nebulizer that are useable with the system of the invention are shown and described in U.S. Pat. No. 7,852,465 entitled System For Measuring liquid Flow Rates issued to Blackford et al. on Dec. 14, 2010; U.S. Pat. No. 8,272,253 entitled Particle Concentration Measurement Technology issued to Grant et al, on Sep. 25, 2012; and U.S. Pat. No. 8,573,034 entitled Residue Concentration Measurement Technology issued to Grant et al on Nov. 5, 2013. The U.S. Pat. No. 8,272,253 describes particular methods and criteria for aerosolizing a colloid. The disclosures of these US patent documents are hereby incorporated by reference.
One unique feature of the nebulizer of this invention is the recessed location of the nebulization region which allows for large droplets (where the residue after evaporation may approach particle sizes of interest) to gravitation ally settle prior to entering the evaporation section.
S=pv/psat,
The critical particle diameter may be calculated using the Kelvin relation:
An alternative embodiment of a CPC 90 shown in
For mixing type CPCs, supersaturation is achieved by mixing two gas streams of different temperatures where the hotter stream contains condensing vapor and the colder stream may or may not contain condensing vapor. If the relationship for the working fluid, dPsat/dTemp is positive, then it is possible to achieve an operating condition where the vapor content in the resulting mixture is higher than the saturated vapor content at the mixed gas temperature. The level of supersaturation can be controlled by varying the temperatures of the gas streams, the flow ratio between the gas streams, and/or explicit control of the vapor content using one of the aforementioned methods described for laminar flow CPCs. Note that mixing type CFCs require a growth section (typically cooled walls) downstream of the mixing region.
For temporally varying supersaturation levels, the size distribution of the particles in the colloid may be inferred by differentiating the measured aerosol concentration as a function of threshold diameter. For spatially varying supersaturation levels, the size distribution is inferred directly (See for example, U.S. Pat. No. 7,656,510). Temporal variation may be incremental with non-sampled periods allowing for steady state conditions, or continuous with active control and or monitoring of flows and temperatures to calculate the saturation ratio and ultimately the minimum detected particle size.
The CPC working fluid is ideally inert and non-toxic with a very low surface energy thereby limiting any material dependence tor the minimum detected particle size. Fluorinated solvents such as 3M FLUORINERT FC-40 and FC-43 have been used as working fluids but they are expensive and have deleterious environmental effects. 3M NOVEC fluids (7500) have similar properties but are cheaper and have less environmental impact. Any of the above CPCs may use these Fluorinated solvents as the working fluid (or as the primary condensing fluid in a two vapor system), much of the solvent can be recovered from the condensing region in the CPC and a downstream secondary condenser. Due to the low miscibility between the fluorinated solvents and water, the fluorinated solvent can be recycled by drawing off of the appropriate strata within the condensed fluid reservoir.
Another embodiment of this invention utilizes an alternate large droplet removal mechanism which may be used in tandem with the existing nebulizer impactor pin described in the text Additionally, an alternate large droplet removal mechanism may be used in place of the previously described impactor pin. Specifically, the additional large droplet removal mechanisms operate by either gravitational settling or by inertial driven capture. Referring to
Vsettling=3E−8*ρpdp2,
Therefore, with sufficient residence time for a given settling distance, large droplets will be preferentially removed from the aerosol. This may be accomplished by either a long tube or by parallel plates. Referring to
a-b show an embodiment of a nebulizer 140 including a large droplet removal means. The assembly includes a jet impactor 141, sheath flow entrance 142 and an impactor nozzle 143. The impacting surface is heated to remove, by evaporation, the liquid introduced by impacted droplets. Data showing enhanced large droplet removal by the jet impactor is shown in
A basic embodiment of the method of the present invention comprises the step of creating fine droplets of the fluid (nebulization) containing particles and dissolved material at concentrations equal to the bulk material. Upon evaporation of the liquid, the gas-home droplet becomes either a particle consisting of non-volatile dissolved material or a particle consisting of a colloid particle and non-volatile dissolved material. The particles are then sampled by a condensation particle counter (CPC) with a temporally or spatially varying detection threshold diameter. In the preferred embodiment, the sample introduced to the nebulizer may consist of the unaltered source colloid, a colloid downstream of a sample introduction device, or downstream of a colloid concentrator (employing evaporation and/or cross flow filtration). In one embodiment, the degree of supersaturation is temporally varied by adjusting the temperatures of the saturated aerosol stream and/or the walls of the transport cavities on the condensing region. These temperatures may either be adjusted in a stepwise manner or continuously ramped. In another embodiment, the degree of supersaturation is temporally varied by adjusting the ratio of a vapor saturated flow to a dry flow, in another embodiment, the degree of supersaturation is temporally varied by adjusting the vapor content, by controlling the mass of vapor delivered to the gas either by adding a controlled amount of liquid to the gas stream or by controlling the exposure of the gas stream to the working fluid surface. And in yet another embodiment, the degree of supersaturation is spatially varied where particles are exposed to an increasing degree of supersaturation. Larger particles (where the onset of condensational growth occurs at a lower supersaturation) have a longer growth period and thus the resulting droplets are larger. By measuring the amount of light scattered by these droplets (larger droplets lead to more scattered light), the size of the original particle can be inferred.
Other embodiments of the method of the invention include, but are not limited to, the following Examples. A base process is for determining the size distribution of particles in a colloid by measuring the size distribution of aerosolized particles using an aerosol particle detector with a variable detection threshold. Particular methods and criteria for aerosolizing the colloid are described in incorporated by reference U.S. Pat. No. 8,272,253. One version of the process involves using a thermally diffusive laminar flow type condensation particle detector.
A. In one route, the detection limit is varied by adjusting the condenser temperature downstream of an aerosol flow saturated with the working vapor, and:
B. In another route, the detection limit is varied by adjusting the temperature of the vapor saturated aerosol and:
C. In a further route, the detection limit is varied by adjusting the temperature of the vapor saturated aerosol and the temperature of the walls in the condenser region, and:
D. In yet another route, the detection limit is adjusted by varying the condensing vapor content prior to the condenser, and
Another version of the process involves using a mixing type condensation particle detector.
Also using mixing type condensation particle detector:
Again using the mixing type condensation particle detector:
Returning to the thermally diffusive laminar flow type condensation particle detector, in another embodiment of method, the temperature of the condenser region may be spatially varied resulting in smaller particles experiencing less time for growth where the initial particle size may be inferred from the size of the resulting droplets.
In a further aspect of the method, where with either a laminar flow or mixing type a condensation particle counter, the process involves controlling the vapor pressure of one or more condensing fluids by explicitly controlling the mass of vapor present in the aerosol prior to the condensing region:
The above methods may be practiced by calculating the differential concentration measured by the CPC at each of the operating condition. The colloidal particle size distribution may be inferred directly by the condensed droplet size distribution. The process may be used to measure the particle size distribution of an unaltered colloid, a diluted colloid, or a colloid passing through a colloid concentrator. Colloid concentration may be accomplished operates using cross flow filtration or by evaporation. Examples of evaporative methods include a semi porous membrane e.g. Porous PTFE (Zeus Corp) bathed in hot, dry gas, or by exposing the liquid surface to hot, dry gas. A preferred condensing vapor is a Fluorinated Solvent (Fluorinert or Novec). In this case, the condensing vapor is preferably recovered by condensation. The condensed working fluid is not miscible with the colloid solvent. And, the recovered working fluid is recycled by drawing it from the appropriate strata within the recovered liquids.
Regarding the method of using a movable impactor pin where an axial force is applied to the pun the force may be constant (e.g. provided by a regulated gas source), the force may vary with pin position (e.g. provided by a spring), or the force may be adjustable (e.g. by adjusting the preload of a spring, or adjustment by changing gas pressure).
The embodiments above are chosen, described and illustrated so that persons skilled in the art will be able to understand the invention and the manner and process of making and using it. The descriptions and the accompanying drawings should be interpreted in the illustrative and not the exhaustive or limited sense. The invention is not intended to be limited to the exact forms disclosed. While the application attempts to disclose all of the embodiments of the invention that are reasonably foreseeable, there may be unforeseeable insubstantial modifications that remain as equivalents. It should be understood by persons skilled in the art that there may be other embodiments than those disclosed which fall within the scope of the invention as defined by the claims. Where a claim, if any, is expressed as a means or step for performing a specified function it is intended that such claim be construed to cover the corresponding structure, material or acts described in the specification and equivalents thereof, including both structural equivalents and equivalent structures, material-based equivalents and equivalent materials, and act-based equivalents and equivalent acts.
A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the US Patent and Trademark Office patent file or records, hut otherwise reserves all copyright rights whatsoever. This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 61/969,478, filed Mar. 24, 2014, and Ser. No. 62/074,931, filed Nov. 4, 2014 which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
5374396 | Blackford | Dec 1994 | A |
6498641 | Schildmeyer | Dec 2002 | B1 |
20070242261 | Liu | Oct 2007 | A1 |
20080137065 | Oberreit | Jun 2008 | A1 |
20080144003 | Blackford | Jun 2008 | A1 |
20090031786 | Takeuchi | Feb 2009 | A1 |
20090078062 | Maheshwari | Mar 2009 | A1 |
20090183554 | Grant | Jul 2009 | A1 |
20100031734 | Zhang | Feb 2010 | A1 |
Entry |
---|
National Academies Publication—Jan. 2005—Sensor Systems for Biological Agent Attacks: Protecting Buildings and Military Bases. |
Number | Date | Country | |
---|---|---|---|
20180224366 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
61969478 | Mar 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14665605 | Mar 2015 | US |
Child | 15945783 | US |